NO20034944D0 - Re-aktiverte T-celler for adoptiv immunoterapi - Google Patents
Re-aktiverte T-celler for adoptiv immunoterapiInfo
- Publication number
- NO20034944D0 NO20034944D0 NO20034944A NO20034944A NO20034944D0 NO 20034944 D0 NO20034944 D0 NO 20034944D0 NO 20034944 A NO20034944 A NO 20034944A NO 20034944 A NO20034944 A NO 20034944A NO 20034944 D0 NO20034944 D0 NO 20034944D0
- Authority
- NO
- Norway
- Prior art keywords
- activated
- cells
- adoptive immunotherapy
- adoptive
- immunotherapy
- Prior art date
Links
- 210000001744 T-lymphocyte Anatomy 0.000 title 1
- 238000009169 immunotherapy Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2818—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/094,667 US20030175272A1 (en) | 2002-03-07 | 2002-03-07 | Re-activated T-cells for adoptive immunotherapy |
PCT/US2002/029520 WO2003077658A1 (en) | 2002-03-07 | 2002-09-17 | Re-activated t-cells for adoptive immunotherapy |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20034944D0 true NO20034944D0 (no) | 2003-11-06 |
Family
ID=27788151
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20034944A NO20034944D0 (no) | 2002-03-07 | 2003-11-06 | Re-aktiverte T-celler for adoptiv immunoterapi |
Country Status (7)
Country | Link |
---|---|
US (1) | US20030175272A1 (pt) |
EP (1) | EP1480519A1 (pt) |
AU (1) | AU2002341697A1 (pt) |
BR (1) | BR0209494A (pt) |
NO (1) | NO20034944D0 (pt) |
WO (1) | WO2003077658A1 (pt) |
ZA (1) | ZA200309435B (pt) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030119185A1 (en) * | 2000-02-24 | 2003-06-26 | Xcyte Therapies, Inc. | Activation and expansion of cells |
US6867041B2 (en) | 2000-02-24 | 2005-03-15 | Xcyte Therapies, Inc. | Simultaneous stimulation and concentration of cells |
US7572631B2 (en) * | 2000-02-24 | 2009-08-11 | Invitrogen Corporation | Activation and expansion of T cells |
US20030235908A1 (en) * | 2000-02-24 | 2003-12-25 | Xcyte Therapies, Inc. | Activation and expansion of cells |
US6797514B2 (en) * | 2000-02-24 | 2004-09-28 | Xcyte Therapies, Inc. | Simultaneous stimulation and concentration of cells |
JP2003534283A (ja) * | 2000-05-25 | 2003-11-18 | エクサイト セラピーズ, インコーポレイテッド | 天然で誘導されたかまたは人工的に誘導された免疫抑制後にt細胞免疫サーベイランスを回復もしくは増強するための方法 |
WO2003024312A2 (en) * | 2001-09-17 | 2003-03-27 | Valeocyte Therapies Llc | Cell therapy system |
US20030170238A1 (en) * | 2002-03-07 | 2003-09-11 | Gruenberg Micheal L. | Re-activated T-cells for adoptive immunotherapy |
US20040175373A1 (en) * | 2002-06-28 | 2004-09-09 | Xcyte Therapies, Inc. | Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation |
US20050084967A1 (en) | 2002-06-28 | 2005-04-21 | Xcyte Therapies, Inc. | Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation |
MXPA05012080A (es) * | 2003-05-08 | 2006-02-22 | Xcyte Therapies Inc | Generacion y aislamiento de celulas t especificas al antigeno. |
EP1663308A1 (en) * | 2003-09-22 | 2006-06-07 | Xcyte Therapies, Inc | Compositions and methods to accelerate hematologic recovery |
DK2573166T3 (da) | 2004-02-26 | 2016-07-04 | Immunovative Therapies Ltd | Fremgangsmåder til fremstilling af T-celler til celleterapi |
US7592431B2 (en) * | 2004-02-26 | 2009-09-22 | Immunovative Therapies, Ltd. | Biodegradable T-cell Activation device |
US8865224B2 (en) * | 2004-10-14 | 2014-10-21 | Immunovative Therapies Ltd. | Allogeneic cellular immunotherapy for opportunistic infection |
WO2007047764A2 (en) | 2005-10-17 | 2007-04-26 | Sloan Kettering Institute For Cancer Research | Wt1 hla class ii-binding peptides and compositions and methods comprising same |
US9265816B2 (en) | 2006-04-10 | 2016-02-23 | Sloan Kettering Institute For Cancer Research | Immunogenic WT-1 peptides and methods of use thereof |
WO2011024791A1 (ja) * | 2009-08-25 | 2011-03-03 | タカラバイオ株式会社 | レチノイン酸存在下でのt細胞集団の製造方法 |
US9233156B2 (en) | 2011-05-03 | 2016-01-12 | Immunovative Therapies Ltd. | Induction of IL-12 using immunotherapy |
KR102229108B1 (ko) | 2011-05-03 | 2021-03-18 | 이뮤노베이티브 테라피스, 엘티디. | 생세포를 포함하는 생물학적 약물을 처리하기 위한 방법 |
RU2011130448A (ru) * | 2011-07-22 | 2013-01-27 | Зао "Евроген" | Методы и наборы для увеличения разнообразия т-клеток |
JP6282598B2 (ja) | 2012-01-13 | 2018-02-21 | メモリアル スローン ケタリング キャンサー センター | 免疫原性wt1ペプチド及びその使用方法 |
CA2898099A1 (en) | 2013-01-15 | 2014-07-24 | David A. Scheinberg | Immunogenic wt-1 peptides and methods of use thereof |
US10815273B2 (en) | 2013-01-15 | 2020-10-27 | Memorial Sloan Kettering Cancer Center | Immunogenic WT-1 peptides and methods of use thereof |
CN109195990A (zh) | 2016-03-30 | 2019-01-11 | Musc研究发展基金会 | 通过靶向糖蛋白a重复优势蛋白(garp)治疗和诊断癌症以及单独或联合提供有效免疫疗法的方法 |
US11464800B2 (en) | 2018-02-09 | 2022-10-11 | Immatics US, Inc. | Methods for manufacturing T cells |
DE102018108996B4 (de) | 2018-02-09 | 2021-10-21 | Immatics US, Inc. | Verfahren zur Herstellung autologer T-Zellen |
Family Cites Families (85)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US31253A (en) * | 1861-01-29 | Machine | ||
US19048A (en) * | 1858-01-05 | Hbnky sanders | ||
US53361A (en) * | 1866-03-20 | Improved apparatus for desiccating eggs | ||
US3883393A (en) * | 1972-05-18 | 1975-05-13 | Us Health Education & Welfare | Cell culture on semi-permeable tubular membranes |
US3821087A (en) * | 1972-05-18 | 1974-06-28 | Dedrick R | Cell culture on semi-permeable tubular membranes |
CH593339A5 (pt) * | 1973-07-02 | 1977-11-30 | Monsanto Co | |
US4087327A (en) * | 1976-04-12 | 1978-05-02 | Monsanto Company | Mammalion cell culture process |
US4200689A (en) * | 1977-11-11 | 1980-04-29 | United States Of America | Method of cell culture using a dual circuit, woven artificial capillary bundle |
US4206015A (en) * | 1977-11-11 | 1980-06-03 | United States Of America | Method of simulation of lymphatic drainage utilizing a dual circuit, woven artificial capillary bundle |
US4220725A (en) * | 1978-04-03 | 1980-09-02 | United States Of America | Capillary cell culture device |
JPS5642584A (en) * | 1979-09-18 | 1981-04-20 | Asahi Chem Ind Co Ltd | Cell cultivation method |
US4301249A (en) * | 1980-07-23 | 1981-11-17 | Merck & Co., Inc. | High titer production of hepatitis A virus |
US5766920A (en) * | 1982-08-11 | 1998-06-16 | Cellcor, Inc. | Ex vivo activation of immune cells |
US5192537A (en) * | 1984-03-30 | 1993-03-09 | Cellcor Inc. | Method of treating renal cell carcinoma using activated mononuclear cells, renal tumor antigen and cimetidine |
US4546083A (en) * | 1983-04-22 | 1985-10-08 | Stolle Research & Development Corporation | Method and device for cell culture growth |
US4804628A (en) * | 1984-10-09 | 1989-02-14 | Endotronics, Inc. | Hollow fiber cell culture device and method of operation |
US4629685A (en) * | 1984-11-16 | 1986-12-16 | Ciba-Geigy Corporation | Process for irradiating polyimides |
US4937071A (en) * | 1985-04-23 | 1990-06-26 | New York University | Method for augmenting immune response |
US4690915A (en) * | 1985-08-08 | 1987-09-01 | The United States Of America As Represented By The Department Of Health And Human Services | Adoptive immunotherapy as a treatment modality in humans |
US5081029A (en) * | 1985-09-25 | 1992-01-14 | Oncogen | Methods of adoptive immunotherapy for treatment of aids |
US4722902A (en) * | 1985-11-04 | 1988-02-02 | Endotronics, Inc. | Apparatus and method for culturing cells, removing waste and concentrating product |
US5002879A (en) * | 1986-05-06 | 1991-03-26 | Merrell Dow Pharmaceuticals | Treatment of tumors with autologous LAK cells, interleukin-2 and an ornithine decarboxylase inhibitor |
US4894342A (en) * | 1986-05-12 | 1990-01-16 | C. D. Medical, Inc. | Bioreactor system |
US4849329A (en) * | 1986-05-30 | 1989-07-18 | E. I. Du Pont De Nemours And Company | Process for preparing lymphokine activated killer cells |
US4971795A (en) * | 1986-07-08 | 1990-11-20 | Biomira, Inc. | Enhancement of the cellular immune response using carbohydrate primed DTH effector cells expressing the CD5+/CD8- phenotype |
WO1988000970A2 (en) * | 1986-08-08 | 1988-02-11 | Regents Of The University Of Minnesota | Method of culturing leukocytes |
US4861589A (en) * | 1987-03-23 | 1989-08-29 | Trustees Of Boston University | Method for therapeutically treating abnormal cells expressing a major histocompatibility complex class II antigen using cytolytic inducer T4 cells |
US4808151A (en) * | 1987-04-27 | 1989-02-28 | E. I. Du Pont De Nemours And Company | Simplified method for the preparation of human lymphokine activated killer cells |
US5399347A (en) * | 1987-06-24 | 1995-03-21 | Autoimmune, Inc. | Method of treating rheumatoid arthritis with type II collagen |
US5041289A (en) * | 1987-11-13 | 1991-08-20 | Becton Dickinson And Company | Method of purging residual tumor cells in vitro with lymphokine activated cytotoxic cells |
US5057423A (en) * | 1987-12-18 | 1991-10-15 | University Of Pittsburgh | Method for the preparation of pure LAK-active lymphocytes |
US5015585A (en) * | 1988-02-23 | 1991-05-14 | Robinson James R | Method and apparatus for culturing and diffusively oxygenating cells on isotropic membranes |
US5123901A (en) * | 1988-02-25 | 1992-06-23 | Carew E Bayne | Method for separating pathogenic or toxic agents from a body fluid and return to body |
US4999298A (en) * | 1988-04-27 | 1991-03-12 | W. R. Grace & Co.-Conn. | Hollow fiber bioreactor culture system and method |
US4973558A (en) * | 1988-04-28 | 1990-11-27 | Endotronics, Inc. | Method of culturing cells using highly gas saturated media |
US6352694B1 (en) * | 1994-06-03 | 2002-03-05 | Genetics Institute, Inc. | Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells |
US6534055B1 (en) * | 1988-11-23 | 2003-03-18 | Genetics Institute, Inc. | Methods for selectively stimulating proliferation of T cells |
US5858358A (en) * | 1992-04-07 | 1999-01-12 | The United States Of America As Represented By The Secretary Of The Navy | Methods for selectively stimulating proliferation of T cells |
FR2640638B1 (fr) * | 1988-12-20 | 1991-02-15 | Commissariat Energie Atomique | Bioreacteur et dispositif pour la culture de cellules animales |
US5242687A (en) * | 1989-03-15 | 1993-09-07 | Tkb Associates Limited Partnership | Method of reducing cellular immune response involving T-cells using CD8-bearing antigen presenting cells |
US5162225A (en) * | 1989-03-17 | 1992-11-10 | The Dow Chemical Company | Growth of cells in hollow fibers in an agitated vessel |
US6093872A (en) * | 1989-05-05 | 2000-07-25 | Systemix, Inc. | Extended human hematopoiesis in a heterologous host |
US5399346A (en) * | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
US5605822A (en) * | 1989-06-15 | 1997-02-25 | The Regents Of The University Of Michigan | Methods, compositions and devices for growing human hematopoietic cells |
US5763266A (en) * | 1989-06-15 | 1998-06-09 | The Regents Of The University Of Michigan | Methods, compositions and devices for maintaining and growing human stem and/or hematopoietics cells |
US5635386A (en) * | 1989-06-15 | 1997-06-03 | The Regents Of The University Of Michigan | Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture |
US5437994A (en) * | 1989-06-15 | 1995-08-01 | Regents Of The University Of Michigan | Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells |
US5728388A (en) * | 1989-10-03 | 1998-03-17 | Terman; David S. | Method of cancer treatment |
US5326763A (en) * | 1989-10-12 | 1994-07-05 | Allergan, Inc. | Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
US5123238A (en) * | 1990-02-09 | 1992-06-23 | Nut Research Company Of Australia Pty Limited | Harvester |
US5656421A (en) * | 1990-02-15 | 1997-08-12 | Unisyn Technologies, Inc. | Multi-bioreactor hollow fiber cell propagation system and method |
US5147289A (en) * | 1990-03-29 | 1992-09-15 | Therakos, Inc | Non-specific immune system enhancement |
US5061620A (en) * | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
US5147784A (en) * | 1990-04-12 | 1992-09-15 | Systemix, Inc. | T-lymphocyte progenitor cell assay |
US5635387A (en) * | 1990-04-23 | 1997-06-03 | Cellpro, Inc. | Methods and device for culturing human hematopoietic cells and their precursors |
DE69120890T2 (de) * | 1990-05-03 | 1997-02-20 | Systemix Inc | Menschliches lymph-gewebe in einem wirt mit angegriffenem immunsystem |
US5229115A (en) * | 1990-07-26 | 1993-07-20 | Immunex Corporation | Adoptive immunotherapy with interleukin-7 |
US5470730A (en) * | 1990-09-28 | 1995-11-28 | Immunex | Method for producing TH -independent cytotoxic T lymphocytes |
US5202254A (en) * | 1990-10-11 | 1993-04-13 | Endotronics, Inc. | Process for improving mass transfer in a membrane bioreactor and providing a more homogeneous culture environment |
US5374549A (en) * | 1991-01-31 | 1994-12-20 | Terumo Corporation | Process of enriching adherent CD4+ T cells from monocyte depleted peripheral blood mononuclear cells with interleukin 2 and interleukin 4 |
US5206008A (en) * | 1991-04-15 | 1993-04-27 | Virginia Commonwealth University | Enhancement of immune response |
US6129916A (en) * | 1991-04-19 | 2000-10-10 | Tanox, Inc. | Method of Increasing activation on proliferation of T cells using antibody-microbead conjugates |
US5872222A (en) * | 1991-04-19 | 1999-02-16 | Tanox Biosystems, Inc. | Conjugates of polymers and antibodies specific for T lymphocytes, and their use as adjuvants |
US5637481A (en) * | 1993-02-01 | 1997-06-10 | Bristol-Myers Squibb Company | Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell |
IE922233A1 (en) * | 1991-07-10 | 1993-01-13 | Augusto C Ochoa | Short-term anti-cd3 stimulation of lymphocytes to increase¹their in vivo activity |
US6204058B1 (en) * | 1992-02-07 | 2001-03-20 | Vasogen Ireland Limited | Treatment of autoimmune diseases |
DE69333433T2 (de) * | 1992-04-01 | 2004-12-02 | The Rockefeller University | Verfahren zur in vitro kultivierung dendritischer vorläuferzellen und deren verwendung zur immunogen herstellung |
US5814295A (en) * | 1992-04-10 | 1998-09-29 | The Ohio State University Research Foundation | Determination of lymph nodes enriched in tumor reactive cells their proliferation and their use in adoptive cellular therapy |
US5466572A (en) * | 1992-09-03 | 1995-11-14 | Systemix, Inc. | High speed flow cytometric separation of viable cells |
AU6586494A (en) * | 1993-04-14 | 1994-11-08 | United States Of America As Represented By The Secretary Of The Navy, The | Transgenic animal model for autoimmune diseases |
WO1995004817A1 (en) * | 1993-08-06 | 1995-02-16 | Cytel Corporation | Methods for ex vivo therapy using peptide-loaded antigen presenting cells for the activation of ctl |
US5409813A (en) * | 1993-09-30 | 1995-04-25 | Systemix, Inc. | Method for mammalian cell separation from a mixture of cell populations |
US5599705A (en) * | 1993-11-16 | 1997-02-04 | Cameron; Robert B. | In vitro method for producing differentiated universally compatible mature human blood cells |
US5622857A (en) * | 1995-08-08 | 1997-04-22 | Genespan Corporation | High performance cell culture bioreactor and method |
US5512444A (en) * | 1994-03-01 | 1996-04-30 | Ludwig Institute For Cancer Research | Method for determining bladder tumors by assaying for MAGE-1,2,3 or 4 |
US5498537A (en) * | 1994-03-09 | 1996-03-12 | Cellco, Inc. | Serum-free production of packaged viral vector |
US5662813A (en) * | 1994-10-21 | 1997-09-02 | Bioseparations, Inc. | Method for separation of nucleated fetal erythrocytes from maternal blood samples |
JP3926842B2 (ja) * | 1995-03-08 | 2007-06-06 | ザ・スクリプス・リサーチ・インステイチユート | 抗原提示系およびt−細胞の活性化方法 |
US5728581A (en) * | 1995-06-07 | 1998-03-17 | Systemix, Inc. | Method of expanding hematopoietic stem cells, reagents and bioreactors for use therein |
EP0852618A1 (en) * | 1995-07-25 | 1998-07-15 | Celltherapy Inc. | Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
US5627070A (en) * | 1995-07-26 | 1997-05-06 | Celltherapy, Inc. | Cell growing device for in vitro cell population expansion |
US5753506A (en) * | 1996-05-23 | 1998-05-19 | Cns Stem Cell Technology, Inc. | Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals |
EP0966523A1 (en) * | 1997-01-31 | 1999-12-29 | Hemosol Inc. | Method for the production of selected lymphocytes |
ID26964A (id) * | 1998-02-19 | 2001-02-22 | Xcyte Therapies Inc | Komposisi dan metode untuk pengaturan pengaktifan limfosit |
WO2003024312A2 (en) * | 2001-09-17 | 2003-03-27 | Valeocyte Therapies Llc | Cell therapy system |
-
2002
- 2002-03-07 US US10/094,667 patent/US20030175272A1/en not_active Abandoned
- 2002-09-17 AU AU2002341697A patent/AU2002341697A1/en not_active Abandoned
- 2002-09-17 BR BR0209494-0A patent/BR0209494A/pt not_active Application Discontinuation
- 2002-09-17 WO PCT/US2002/029520 patent/WO2003077658A1/en not_active Application Discontinuation
- 2002-09-17 EP EP02775847A patent/EP1480519A1/en not_active Withdrawn
-
2003
- 2003-11-06 NO NO20034944A patent/NO20034944D0/no not_active Application Discontinuation
- 2003-12-04 ZA ZA200309435A patent/ZA200309435B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2002341697A1 (en) | 2003-09-29 |
BR0209494A (pt) | 2005-08-23 |
ZA200309435B (en) | 2006-05-31 |
EP1480519A1 (en) | 2004-12-01 |
US20030175272A1 (en) | 2003-09-18 |
WO2003077658A1 (en) | 2003-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20034944D0 (no) | Re-aktiverte T-celler for adoptiv immunoterapi | |
AU2003272582A8 (en) | Re-activated t-cells for adoptive immunotherapy | |
CY2016009I2 (el) | Ενωσεις για την αναστολη του ενζυμου πρωτεασωματος | |
DK1897548T4 (da) | T-celleregulering | |
DE60302032D1 (de) | Künstliche Bandscheibe | |
DE60330151D1 (de) | Brennstoffzellensystem | |
DE50305407D1 (de) | Bandscheibenprothese | |
DE60316596D1 (de) | Brennstoffzellensystem | |
DK1835923T3 (da) | Skemaer til intra-artikulær visco-supplering | |
EP1729798A4 (en) | THERAPY USING ANTIGEN-SPECIFIC T LYMPHOCYTES | |
DE10347121A8 (de) | Ladegerät | |
DK1733039T3 (da) | Forbedret bakteriel værtscelle til direkte ekspression af peptider | |
IS8570A (is) | Stoðfrumulaus framhaldsrækt stofnfrumna | |
NO20051885L (no) | Lastehylle | |
DE602004022088D1 (de) | Zellkultivierungskolben | |
DE60331474D1 (de) | Brennstoffzellensystem | |
DE60331959D1 (de) | Brennstoffzellensystem | |
DE60332334D1 (de) | Silikon enthaltende phenyl amidderivate verwendbar als mikrobiozide | |
AU2003272598A1 (en) | Th1 cell adoptive immunotherapy | |
DE60312367D1 (de) | Brennstoffzellensystem | |
DE502004008433D1 (de) | Wägezelle | |
DK1482971T3 (da) | Strategi til retroviral immunoterapi | |
FI20020607A (fi) | Kantoaineen hionta | |
ATE516919T1 (de) | Schleifscheibe | |
DE10303750B8 (de) | Ausgleichsscheibenträger |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |